Skip to contentSkip to filters

We use cookies for analytics.

Position

Group Lead, Immunology

NewLimit

Related content

About

NewLimit develops medicines for age-related disease by reprogramming the epigenome to restore regenerative potential in aged and diseased cells, using functional genomics, pooled perturbation screening and machine learning to study epigenetic ageing at scale. The Immunology program develops reprogramming medicines that restore youthful function in aged T cells for inflammatory and infectious diseases, with an emphasis on T cell and regulatory T cell biology.

The group lead directs scientists and research associates, develops functional assays and pre-clinical disease models, evaluates reprogramming payloads to select leads and pre-clinical candidates, and works with the single-cell technology, epigenetic editing and predictive modelling teams to design, build and test reprogramming interventions. The salary range is $180,000–$240,000 USD.

Requirements

Ph.D. in cell biology, immunology or a related field, or comparable industry experience; experience leading a team and managing direct reports; experience with therapeutics development, ideally leading part of a discovery or development process in immunology, infectious or inflammatory disease; deep knowledge of immunology and lymphocyte biology. Nice to have: T cell functional assays and pre-clinical models, in vivo nucleic-acid delivery, pooled screening, transgenic construct design, and knowledge of ageing biology, computational biology and machine learning.

Topics

Source: NewLimit